Hyundai Motor India Q4 PAT slips 4% to ₹1,614 crore, board okays dividend of Rs 21


The company on Friday said it would introduce 26 products (including refreshed models) by FY2030, comprising 20 ICEs and 6 EVs. Additionally, it would introduce hybrids. 

The company on Friday said it would introduce 26 products (including refreshed models) by FY2030, comprising 20 ICEs and 6 EVs. Additionally, it would introduce hybrids. 
| Photo Credit: AMIT DAVE

Hyundai Motor India Ltd. (HMIL) for the fourth quarter ended March 31, 2025 reported 4% drop in consolidated net profit to Rs. 1,614 crore compared with Rs. 1,677 crore in the year ago period reflecting the challenging operating environment.

The company’s consolidated revenue during the quarter grew marginally by 1.5% to Rs. 17,940 crore.

For FY25 the company’s net profit dropped 7% to YoY Rs.5,640 crore and revenue remained flat at Rs. 69,193 crore.

The board has recommended a dividend of Rs. 21 per share for FY25.

The company on Friday said it would introduce 26 products (including refreshed models) by FY2030 comprising 20 ICE and 6 EVs. Additionally, it will introduce hybrids. The company said the new plant in Pune would be operational in the third quarter of FY26 giving impetus to its growth in India.

Unsoo Kim, MD, HMIL said, “FY25 business performance demonstrates our ability to navigate the tides by responding quickly to the ever-changing customer aspirations.” 

“Hyundai’s strong brand presence in key global emerging markets enabled us to endure headwinds and sustain export volumes during the year. The year gone by signifies our resilience in the financial performance by way of sustained revenues & healthy operating margins attributable to improved realisations & effective cost control measures,” he said.

“Looking ahead, we remain cautiously optimistic on domestic demand outlook in near-term amid prevailing macro-turbulences and weakening customer sentiments,” he said.

“While we expect our FY26 domestic growth to be broadly in line with Industry estimates of low-single digit, we are aiming for 7-8% volume growth in exports by improved focus and leveraging our strong brand equity and legacy in the key emerging markets,” he added.



Source link

  • Related Posts

    Lupin, China’s SUP ink pact for COPD drug Tiotropium DPI

    Lupin has signed a license and supply agreement with Sino Universal Pharmaceuticals (SUP) for commercialisation of chronic obstructive pulmonary disease drug Tiotropium Dry Powder Inhaler, 18 mcg/capsule, in the Chinese…

    Continue reading
    India to export 150 locomotives to Africa worth over ₹3,000 crore

    “These locomotives are fitted with Distributed Power Wireless Control System, or DPWCS, for synchronised operations and superior freight handling,” a Railways Ministry spokesperson said. Photo: https://www.wabteccorp.com/ India will supply 150…

    Continue reading

    Leave a Reply

    Your email address will not be published. Required fields are marked *